Carlos Grande - From the Hematology Departments of, Hospital Universitario 12 de Octubre

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 202 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

A Comprehensive Single-Cell Multi-Omic Analysis to Depict the Biological Heterogeneity of Follicular and Large B-Cell Lymphomas

Sofía Huerga-Domínguez,Beñat Ariceta,Paula Aguirre-Ruiz,Patxi San Martín-Uriz,Sarai Sarvide,Álvaro López-Janeiro, Diego Alignani, Aintzane López-López,Emma Muiños-López,Marta Abengozar, Santiago Browne,Rocío Figueroa,Carlos Grande,Sergio Roa,Juan Roberto Rodríguez-Madoz, Amaia Vilas-Zornoza,Felipe Prósper, Miguel Canales

Clinical Lymphoma Myeloma & Leukemia (2024): S155-S155

Cited0Views0Bibtex

Ibrutinib in Combination with R-Gemox-D in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Phase II Clinical Trial of the Geltamo Group

Beatriz Rey-Bua,Carlos Grande,Jose J. Sanchez Blanco,Pau Abrisqueta,Antonio Gutierrez,Angel Ramirez Payer,Eva Gine, Izaskun Zeberio Etxetxipia,Maria J. Terol,Fatima de la Cruz Vicente,Rafel Andreu,Maria J. Ramirez,Adolfo de la Fuente, Maria C. Viguria,Maria J. Penarrubia,Ana Jimenez-Ubieto,Santiago Montes-Moreno, Armando Lopez-Guillermo,Maria D. Caballero,Alejandro Martin Garcia-Sancho

CLINICAL CANCER RESEARCHno. 17 (2024): 3704-3714

Cited0Views0WOSBibtex

Phase 1/2 of EO2463 Immunotherapy As Monotherapy and in Combination with Lenalidomide And/or Rituximab in Indolent NHL (EONHL1-20/SIDNEY)

Jose Caetano Villasboas, Danielle Wallace,Stephen Douglas Smith,Carlos Grande,Jean Pierre Marolleau,Francesc Bosch,Antonio Pinto,Luca Arcaini,Reid Merryman,Ramon Garcia Sanz,Pier Luigi Zinzani, Lucie Aubergeon,Laurent Chene,Jan Fagerberg,Philippe Armand,Jonathan W. Friedberg, Stephen M. Ansell

Journal of Clinical Oncologyno. 16_suppl (2024): 7058-7058

Cited0Views0Bibtex

Impact of the Current Treatments on the Survival of Patients with Mantle Cell Lymphoma (MCL): A Real-Life Study on Behalf of the Spanish Group of Lymphoma (GELTAMO)

Bloodno. Supplement 1 (2023): 1678-1678

Cited0Views0Bibtex

Phase 1 Trial of EO2463 Peptide‐based Immunotherapy As Monotherapy and in Combination with Lenalidomide and Rituximab in Indolent Non‐hodgkin Lymphoma; EONHL1‐20/SIDNEY

A. A. Pinto,F. Bosch,J. C. Villasboas Bisneto,R. García Sanz,C. Grande Garcia,S. D. Smith, D. S. Wallace,L. Arcaini,R. Merryman,J. Marolleau,R. De Filippi,L. Chêne,C. Bonny,J. Fagerberg,J. W. Friedberg, S. Ansel,P. Armand,P. L. Zinzani

Hematological Oncologyno. S2 (2023): 581-582

Cited0Views0Bibtex

Subcutaneous Epcoritamab Plus Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma from EPCORE NHL-5

Irit Avivi Mazza,Won Seog Kim, Shen Ko,Carlos Grande,David Lavie,David Chism, Mostafa Seliem,Edwin E. Jeng,Neha Joshi,Satya Siddani,Wissam Assaily,Mariana Sacchi,Minh Dinh,Abraham Avigdor

Blood (2023): 438

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn